ZOLL Medical Corporation (ZOLL) Earnings Preview From Northland Securities
January 26, 2010 10:48 AM
Analysts at Northland Securities have released an earnings preview for ZOLL Medical Corporation (NASDAQ: ZOLL).
ZOLL will report earnings for the first quarter of fiscal year 2010 on 28 January, 2010. Analysts’ expect global revenues to be at $100.1 million for the quarter with an EPS of $0.10. According to analysts, the hospital market has shown improvement. Although they expect a decline in revenue from the North American hospital segment, the $26.2 million revenue estimate for that segment represents a 29% increase from last year’s level.
Analysts have included relatively conservative estimate for military orders and temperature management in their forecast and believe that either can provide an upside to the revenue estimates. Analysts do not expect a strong result from the pre-hospital market. However, analysts believe that the revenues from LifeVest will be quiet healthy.
ZOLL’s international sales are difficult to forecast, according to analysts; however, they believe the underlying market is getting healthier and expect ZOLL to gain market share. Analysts at Northland have maintained an Outperform rating for ZOLL and raised the price target to $30 from $26.
